| LP306592-9 | Parathyrin.intact^2nd specimen | COMPONENT | 1 |
| LP306593-7 | Parathyrin.intact^30M post XXX challenge | COMPONENT | 2 |
| LP306594-5 | Parathyrin.intact^3rd specimen | COMPONENT | 1 |
| LP306595-2 | Parathyrin.intact^4th specimen | COMPONENT | 1 |
| LP306596-0 | Parathyrin.intact^5M post excision | COMPONENT | 2 |
| LP306598-6 | Parathyrin.intact^5th specimen | COMPONENT | 1 |
| LP306599-4 | Parathyrin.intact^6th specimen | COMPONENT | 1 |
| LP30660-2 | CD10+CD19+ cells | COMPONENT | 1 |
| LP306600-0 | Parathyrin.intact^7th specimen | COMPONENT | 1 |
| LP306601-8 | Parathyrin.intact^8th specimen | COMPONENT | 1 |
| LP306602-6 | Parathyrin.intact^baseline | COMPONENT | 2 |
| LP306603-4 | Parathyrin.intact^post excision | COMPONENT | 1 |
| LP306604-2 | Parathyrin.intact^post XXX challenge | COMPONENT | 1 |
| LP306605-9 | Parathyrin^10M post excision | COMPONENT | 2 |
| LP306608-3 | Parathyrin^baseline | COMPONENT | 2 |
| LP30661-0 | CD13+CD33+ cells | COMPONENT | 1 |
| LP306610-9 | Patient symptoms^1.5H post dose lactose PO | COMPONENT | 2 |
| LP306611-7 | Patient symptoms^1H post dose lactose PO | COMPONENT | 2 |
| LP306612-5 | Patient symptoms^2.5H post dose lactose PO | COMPONENT | 2 |
| LP306613-3 | Patient symptoms^2H post dose lactose PO | COMPONENT | 2 |
| LP306614-1 | Patient symptoms^30M post dose lactose PO | COMPONENT | 2 |
| LP306615-8 | Patient symptoms^3H post dose lactose PO | COMPONENT | 2 |
| LP306616-6 | Patient symptoms^pre dose lactose PO | COMPONENT | 2 |
| LP306617-4 | pH^1st specimen post dose sincalide | COMPONENT | 1 |
| LP306618-2 | pH^2nd specimen post dose sincalide | COMPONENT | 1 |
| LP306619-0 | pH^3rd specimen post dose sincalide | COMPONENT | 1 |
| LP30662-8 | 1 day post 50 ug Candida albicans intradermal | CHALLENGE | |
| LP306620-8 | pH^4th specimen post dose sincalide | COMPONENT | 1 |
| LP306621-6 | pH^5th specimen post dose sincalide | COMPONENT | 1 |
| LP306622-4 | Phenylalanine/Tyrosine^post therapeutic diet | COMPONENT | 1 |
| LP306623-2 | Phenylalanine^post therapeutic diet | COMPONENT | 1 |
| LP306624-0 | Pregnanediol^2D post dose dexamethasone | COMPONENT | 2 |
| LP306625-7 | Pregnanediol^2D post high dose dexamethasone | COMPONENT | 2 |
| LP306626-5 | Pregnanediol^pre dose dexamethasone | COMPONENT | 2 |
| LP306627-3 | Pregnanediol^pre high dose dexamethasone | COMPONENT | 2 |
| LP306628-1 | Pregnenolone^1H post 250 ug corticotropin | COMPONENT | 1 |
| LP306629-9 | Pregnenolone^1st specimen post XXX challenge | COMPONENT | 1 |
| LP30663-6 | 2 days post 50 ug Candida albicans intradermal | CHALLENGE | |
| LP306630-7 | Pregnenolone^2nd specimen post XXX challenge | COMPONENT | 1 |
| LP306631-5 | Pregnenolone^3rd specimen post XXX challenge | COMPONENT | 1 |
| LP306632-3 | Pregnenolone^4th specimen post XXX challenge | COMPONENT | 1 |
| LP306633-1 | Pregnenolone^5th specimen post XXX challenge | COMPONENT | 1 |
| LP306634-9 | Pregnenolone^6th specimen post XXX challenge | COMPONENT | 1 |
| LP306635-6 | Pregnenolone^7th specimen post XXX challenge | COMPONENT | 1 |
| LP306636-4 | Pregnenolone^baseline | COMPONENT | 1 |
| LP306637-2 | Progesterone^1.5H post XXX challenge | COMPONENT | 2 |
| LP306638-0 | Progesterone^10th specimen post XXX challenge | COMPONENT | 2 |
| LP306639-8 | Progesterone^15M post XXX challenge | COMPONENT | 2 |
| LP30664-4 | 1 day post 0.1 mL mumps intradermal | CHALLENGE | |
| LP306640-6 | Progesterone^1H post XXX challenge | COMPONENT | 2 |